XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Deficit - USD ($)
Common Stock
Additional Paid-In Capital
Retained Earnings (deficits)
Total
Beginning balance, shares at Dec. 31, 2017 25,046,000      
Beginning balance, value at Dec. 31, 2017 $ 25,036 $ 3,258,116 $ (4,644,180) $ (1,361,028)
Clawback of stock granted, shares (375,000)      
Clawback of stock granted, value $ (375) 375
Payment of outstanding balance for PPM 80,000 80,000
Stock Based Compensation 1,345,825 1,345,825
Stock grant program vesting, shares 558,833      
Stock grant program vesting, value $ 568 (568)
Warrants 4,525 4,525
Net loss (3,895,873) (3,895,873)
Ending balance, shares at Dec. 31, 2018 25,229,833      
Ending balance, value at Dec. 31, 2018 $ 25,230 4,688,272 (8,540,053) (3,826,551)
Net loss       (5,719,404)
Ending balance, shares at Sep. 30, 2019 26,981,466      
Ending balance, value at Sep. 30, 2019 $ 26,981 8,967,004 (14,259,457) (5,265,472)
Beginning balance, shares at Dec. 31, 2018 25,229,833      
Beginning balance, value at Dec. 31, 2018 $ 25,230 4,688,272 (8,540,053) (3,826,551)
Stock Based Compensation 1,830,426 1,830,426
Stock Options Issued for loan term revisions, value 37,829 37,829
Stock grants issued for loan term revisions, shares 16,000      
Stock grants issued for loan term revisions, value $ 16 31,284 31,300
Stock grant program vesting, shares 1,360,966      
Stock grant program vesting, value $ 1,360 (1,360)
Warrants   614,041   614,041
Stock issuance related to conversion of convertible debentures, shares 1,102,513      
Stock issuance related to conversion of convertible debentures, value $ 1,103 2,655,934 2,657,037
Stock issuance related to acquisition, shares 500,000      
Stock issuance related to acquisition, value $ 500 999,500 1,000,000
Equity value of exercise price associated with convertible debentures   719,479 719,479
Broker warrants associated with issuance of convertible debentures   278,678 278,678
Net loss (8,350,573) (8,350,573)
Ending balance, shares at Dec. 31, 2019 28,209,312      
Ending balance, value at Dec. 31, 2019 $ 28,209 11,854,083 (16,890,626) (5,008,334)
Beginning balance, shares at Jun. 30, 2019 25,820,633      
Beginning balance, value at Jun. 30, 2019 $ 25,821 8,438,943 (11,449,927) (2,985,163)
Stock Based Compensation   509,219   509,219
Stock Options Issued for loan term revisions, value   20,002   20,002
Stock grant program vesting, shares 1,160,833      
Stock grant program vesting, value $ 1,160 (1,160)    
Net loss     (2,809,530) (2,809,530)
Ending balance, shares at Sep. 30, 2019 26,981,466      
Ending balance, value at Sep. 30, 2019 $ 26,981 8,967,004 (14,259,457) (5,265,472)
Beginning balance, shares at Dec. 31, 2019 28,209,312      
Beginning balance, value at Dec. 31, 2019 $ 28,209 11,854,083 (16,890,626) (5,008,334)
Net loss       (3,959,882)
Ending balance, shares at Sep. 30, 2020 28,272,285      
Ending balance, value at Sep. 30, 2020 $ 28,272 14,118,289 (20,850,508) (6,703,947)
Beginning balance, shares at Jun. 30, 2020 28,830,978      
Beginning balance, value at Jun. 30, 2020 $ 28,830 13,522,833 (20,156,227) (6,604,564)
Clawback of stock granted, shares (1,000,000)      
Clawback of stock granted, value $ (1,000) 1,000    
Stock grant program vesting, shares 131,667      
Stock grant program vesting, value $ 132 (132)    
Stock issuance related to acquisition, shares 250,000      
Stock issuance related to acquisition, value $ 250 154,750   155,000
Stock grant to satisfy accounts payable, shares 9,640      
Stock grant to satisfy accounts payable, value $ 10 9,630   9,640
Stock issued for lease revision, shares 50,000      
Stock issued for lease revision, value $ 50 30,950   31,000
Net loss     (694,281) (694,281)
Ending balance, shares at Sep. 30, 2020 28,272,285      
Ending balance, value at Sep. 30, 2020 $ 28,272 $ 14,118,289 $ (20,850,508) $ (6,703,947)